Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant
about
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dinutuximab, Sargramostim, and ...... ndergoing Stem Cell Transplant
@en
type
label
Dinutuximab, Sargramostim, and ...... ndergoing Stem Cell Transplant
@en
prefLabel
Dinutuximab, Sargramostim, and ...... ndergoing Stem Cell Transplant
@en
P4844
P1476
A Pilot Induction Regimen Inco ...... gnosed High-Risk Neuroblastoma
@en
P3098
NCT03786783
P4844
P580
2019-01-14T00:00:00Z
P582
2021-07-31T00:00:00Z